Your browser doesn't support javascript.
loading
The combined serum levels of miR-375 and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer.
Wach, Sven; Al-Janabi, Omar; Weigelt, Katrin; Fischer, Kersten; Greither, Thomas; Marcou, Marios; Theil, Gerit; Nolte, Elke; Holzhausen, Hans-Juergen; Stöhr, Robert; Huppert, Verena; Hartmann, Arndt; Fornara, Paolo; Wullich, Bernd; Taubert, Helge.
Afiliación
  • Wach S; Department of Urology, Universitätsklinikum Erlangen, Friedrich Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Al-Janabi O; Department of Urology, Universitätsklinikum Erlangen, Friedrich Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Weigelt K; Department of Urology, Universitätsklinikum Erlangen, Friedrich Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Fischer K; Department of Urology, Martin Luther University Halle-Wittenberg, Halle, Germany.
  • Greither T; Center for Reproductive Medicine and Andrology, Martin Luther University Halle-Wittenberg, Halle, Germany.
  • Marcou M; Department of Urology, Martin Luther University Halle-Wittenberg, Halle, Germany.
  • Theil G; Center for Reproductive Medicine and Andrology, Martin Luther University Halle-Wittenberg, Halle, Germany.
  • Nolte E; Department of Urology, Martin Luther University Halle-Wittenberg, Halle, Germany.
  • Holzhausen HJ; Department of Urology, Universitätsklinikum Erlangen, Friedrich Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Stöhr R; Institute of Pathology, Martin Luther University Halle-Wittenberg, Halle, Germany.
  • Huppert V; Institute of Pathology, Universitätsklinikum Erlangen, Friedrich Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Hartmann A; Department of Urology, Universitätsklinikum Erlangen, Friedrich Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Fornara P; Institute of Pathology, Universitätsklinikum Erlangen, Friedrich Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Wullich B; Department of Urology, Martin Luther University Halle-Wittenberg, Halle, Germany.
  • Taubert H; Department of Urology, Universitätsklinikum Erlangen, Friedrich Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.
Int J Cancer ; 137(6): 1406-16, 2015 Sep 15.
Article en En | MEDLINE | ID: mdl-25754273
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Biomarcadores de Tumor / MicroARNs / Receptores del Activador de Plasminógeno Tipo Uroquinasa Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int J Cancer Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Biomarcadores de Tumor / MicroARNs / Receptores del Activador de Plasminógeno Tipo Uroquinasa Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int J Cancer Año: 2015 Tipo del documento: Article